23andMe Cleared to Report 41 More BRCA Mutations Posted OnAugust 31, 2023 byPriscilla Kennedy The FDA is allowing 23andMe to report 41 more BRCA1 and BRCA2 mutations in its genetic test results. Read the Complete Article Here Previous PostFDA approves niraparib and abiraterone acetate plus prednisone for BRCA-mutated metastatic castration-resistant prostate cancerNext Post2024 Funding Announcement